Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subash Babu

Showing results (221-230 of 295) with videos related to

Pageof 30
Sort By:
Frontiers in Pharmacology|October 21, 2021
Evaluation of Biosafety, Antiobesity, and Endothelial Cells Proliferation Potential of Basil Seed Extract Loaded Organic Solid Lipid NanoparticlePandurangan Subash-Babu, Nada Al-Saran, Ghedeir M Alshammari, et al.
Cytokine|July 13, 2019
Plasma levels of C-reactive protein, matrix metalloproteinase-7 and lipopolysaccharide-binding protein distinguish active pulmonary or extrapulmonary tuberculosis from uninfected controls in childrenVictor V S Albuquerque, Nathella Pavan Kumar, Kiyoshi F Fukutani, et al.
Immunity, Inflammation and Disease|February 28, 2024
Elucidating systemic immune responses to acute and convalescent SARS-CoV-2 infection in children and elderly individualsAnuradha Rajamanickam, Pavan Kumar Nathella, Aishwarya Venkataraman, et al.
Ebiomedicine|January 10, 2017
Unbiased Identification of Blood-based Biomarkers for Pulmonary Tuberculosis by Modeling and Mining Molecular Interaction NetworksAwanti Sambarey, Abhinandan Devaprasad, Abhilash Mohan, et al.
Tuberculosis (Edinburgh, Scotland)|November 7, 2015
Modulation of pro- and anti-inflammatory cytokines in active and latent tuberculosis by coexistent Strongyloides stercoralis infectionParakkal Jovvian George, Nathella Pavan Kumar, Jeeva Jaganathan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2020
Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary TuberculosisNathella P Kumar, Kadar Moideen, Arul Nancy, et al.
JAMA Network Open|December 1, 2020
Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary TuberculosisNathella P Kumar, Kadar Moideen, Arul Nancy, et al.
The Journal of Infectious Diseases|June 10, 2009
Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1Subash Babu, Sajid Q Bhat, N Pavan Kumar, et al.
Open Forum Infectious Diseases|March 12, 2025
Impact of <i>Strongyloides stercoralis</i> Coinfection on Disease Severity and Treatment Outcomes in Pulmonary TuberculosisNathella Pavan Kumar, Saravanan Munisankar, Bindu Dasan, et al.
Frontiers in Cellular and Infection Microbiology|July 6, 2017
Th2/1 Hybrid Cells Occurring in Murine and Human Strongyloidiasis Share Effector Functions of Th1 CellsCristin N Bock, Subash Babu, Minka Breloer, et al.
Pageof 30

Showing results (221-230 of 295) with videos related to

Sort By:
Pageof 30
Frontiers in Pharmacology|October 21, 2021
Evaluation of Biosafety, Antiobesity, and Endothelial Cells Proliferation Potential of Basil Seed Extract Loaded Organic Solid Lipid NanoparticlePandurangan Subash-Babu, Nada Al-Saran, Ghedeir M Alshammari, et al.
Cytokine|July 13, 2019
Plasma levels of C-reactive protein, matrix metalloproteinase-7 and lipopolysaccharide-binding protein distinguish active pulmonary or extrapulmonary tuberculosis from uninfected controls in childrenVictor V S Albuquerque, Nathella Pavan Kumar, Kiyoshi F Fukutani, et al.
Immunity, Inflammation and Disease|February 28, 2024
Elucidating systemic immune responses to acute and convalescent SARS-CoV-2 infection in children and elderly individualsAnuradha Rajamanickam, Pavan Kumar Nathella, Aishwarya Venkataraman, et al.
Ebiomedicine|January 10, 2017
Unbiased Identification of Blood-based Biomarkers for Pulmonary Tuberculosis by Modeling and Mining Molecular Interaction NetworksAwanti Sambarey, Abhinandan Devaprasad, Abhilash Mohan, et al.
Tuberculosis (Edinburgh, Scotland)|November 7, 2015
Modulation of pro- and anti-inflammatory cytokines in active and latent tuberculosis by coexistent Strongyloides stercoralis infectionParakkal Jovvian George, Nathella Pavan Kumar, Jeeva Jaganathan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2020
Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary TuberculosisNathella P Kumar, Kadar Moideen, Arul Nancy, et al.
JAMA Network Open|December 1, 2020
Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary TuberculosisNathella P Kumar, Kadar Moideen, Arul Nancy, et al.
The Journal of Infectious Diseases|June 10, 2009
Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1Subash Babu, Sajid Q Bhat, N Pavan Kumar, et al.
Open Forum Infectious Diseases|March 12, 2025
Impact of <i>Strongyloides stercoralis</i> Coinfection on Disease Severity and Treatment Outcomes in Pulmonary TuberculosisNathella Pavan Kumar, Saravanan Munisankar, Bindu Dasan, et al.
Frontiers in Cellular and Infection Microbiology|July 6, 2017
Th2/1 Hybrid Cells Occurring in Murine and Human Strongyloidiasis Share Effector Functions of Th1 CellsCristin N Bock, Subash Babu, Minka Breloer, et al.
Pageof 30